Drug Information Analysis Service

Abstract

Get full access to this article

View all access options for this article.

References

Block

. Restenosis after percutaneous transluminal coronary angioplasty—anatomic and pathophysiological mechanisms, strategies for prevention. Circulation 1990; 81 (suppl IV): IV2–4.

Lembo

Black

AJR

Roubin

, Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and type of acute complications of percutaneous transluminal coronary angioplasty. Am J Cardiol 1990; 65: 422–6.

Schwartz

Bourassa

Lesperance

, Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 1988; 318: 1714–9.

Barnathan

Schwartz

Taylor

, Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty. Circulation 1987; 76: 125–34.

Chesebro

Fuster

. Platelet-inhibitor drugs before and after coronary artery bypass surgery and coronary angioplasty: The basis of their use, data from animal studies, clinical trial data and current recommendations. Cardiology 1986; 73: 292–305.

Harker

. Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. Am J Cardiol 1987; 60: 20–8B.

Fitzgerald

. Dipyridamole. N Engl J Med 1987; 316: 1247–57.

Schwartz

Lesperance

Bourassa

, The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplasty. Am Heart J 1990; 119: 232–6.